BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19332039)

  • 1. Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.
    Loftus LT; Gala R; Yang T; Jessick VJ; Ashley MD; Ordonez AN; Thompson SJ; Simon RP; Meller R
    Brain Res; 2009 May; 1272():71-80. PubMed ID: 19332039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells.
    Lee YJ; Miyake S; Wakita H; McMullen DC; Azuma Y; Auh S; Hallenbeck JM
    J Cereb Blood Flow Metab; 2007 May; 27(5):950-62. PubMed ID: 16955077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose.
    Lee YJ; Bernstock JD; Nagaraja N; Ko B; Hallenbeck JM
    J Neurochem; 2016 Jul; 138(1):101-16. PubMed ID: 27087120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of preconditioning treatments to protect near-pure cortical neuronal cultures from in vitro ischemia induced acute and delayed neuronal death.
    Meloni BP; Majda BT; Knuckey NW
    Brain Res; 2002 Feb; 928(1-2):69-75. PubMed ID: 11844473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major role of the PI3K/Akt pathway in ischemic tolerance induced by sublethal oxygen-glucose deprivation in cortical neurons in vitro.
    Bhuiyan MI; Jung SY; Kim HJ; Lee YS; Jin C
    Arch Pharm Res; 2011 Jun; 34(6):1023-34. PubMed ID: 21725824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of ceramide in ischemic tolerance induced by preconditioning with sublethal oxygen-glucose deprivation in primary cultured cortical neurons of rats.
    Bhuiyan MI; Islam MN; Jung SY; Yoo HH; Lee YS; Jin C
    Biol Pharm Bull; 2010; 33(1):11-7. PubMed ID: 20045928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation participates in induction of ischemic tolerance.
    Lee YJ; Castri P; Bembry J; Maric D; Auh S; Hallenbeck JM
    J Neurochem; 2009 Apr; 109(1):257-67. PubMed ID: 19200349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism underlying rapid ischemic tolerance.
    Meller R; Thompson SJ; Lusardi TA; Ordonez AN; Ashley MD; Jessick V; Wang W; Torrey DJ; Henshall DC; Gafken PR; Saugstad JA; Xiong ZG; Simon RP
    J Neurosci; 2008 Jan; 28(1):50-9. PubMed ID: 18171922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic Preconditioning Protects Astrocytes against Oxygen Glucose Deprivation Via the Nuclear Erythroid 2-Related Factor 2 Pathway.
    Narayanan SV; Dave KR; Perez-Pinzon MA
    Transl Stroke Res; 2018 Apr; 9(2):99-109. PubMed ID: 29103101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO and ischemic tolerance.
    Lee YJ; Hallenbeck JM
    Neuromolecular Med; 2013 Dec; 15(4):771-81. PubMed ID: 23775726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphorylation of ribosomal protein S6 is a molecular mechanism underlying ischemic tolerance induced by either hibernation or preconditioning.
    Miyake S; Wakita H; Bernstock JD; Castri P; Ruetzler C; Miyake J; Lee YJ; Hallenbeck JM
    J Neurochem; 2015 Dec; 135(5):943-57. PubMed ID: 26375300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanosine modulates SUMO2/3-ylation in neurons and astrocytes via adenosine receptors.
    Zanella CA; Tasca CI; Henley JM; Wilkinson KA; Cimarosti HI
    Purinergic Signal; 2020 Sep; 16(3):439-450. PubMed ID: 32892251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal Injury.
    Tong L; Wu Z; Ran M; Chen Y; Yang L; Zhang H; Zhang L; Dong H; Xiong L
    Mol Neurobiol; 2015; 51(3):1221-31. PubMed ID: 24961570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma.
    Zeng Y; Xie K; Dong H; Zhang H; Wang F; Li Y; Xiong L
    Brain Res; 2012 May; 1452():140-50. PubMed ID: 22444276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning induces tolerance by suppressing glutamate release in neuron culture ischemia models.
    Tauskela JS; Aylsworth A; Hewitt M; Brunette E; Mealing GA
    J Neurochem; 2012 Jul; 122(2):470-81. PubMed ID: 22607164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons.
    Lin CH; Chen PS; Gean PW
    Eur J Pharmacol; 2008 Jul; 589(1-3):85-93. PubMed ID: 18589412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure and rescue of preconditioning-induced neuroprotection in severe stroke-like insults.
    Tauskela JS; Aylsworth A; Hewitt M; Brunette E; Blondeau N
    Neuropharmacology; 2016 Jun; 105():533-542. PubMed ID: 26867506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia.
    Lee YJ; Johnson KR; Hallenbeck JM
    PLoS One; 2012; 7(10):e47787. PubMed ID: 23094087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.
    Li YX; Ding SJ; Xiao L; Guo W; Zhan Q
    Neurosci Bull; 2008 Apr; 24(2):89-95. PubMed ID: 18369388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumoylation of LYS590 of NCX3 f-Loop by SUMO1 Participates in Brain Neuroprotection Induced by Ischemic Preconditioning.
    Cuomo O; Pignataro G; Sirabella R; Molinaro P; Anzilotti S; Scorziello A; Sisalli MJ; Di Renzo G; Annunziato L
    Stroke; 2016 Apr; 47(4):1085-93. PubMed ID: 26979866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.